NCT04899687: Study of Dextromethorphan in OCD and Related Disorders
- State
- Under way
- Phase
- Phase 2
- People
- 60 planned
- Started
- 20 Jan 2022
- Primary completion
- 1 Apr 2027
- Arms
- Group A: fluoxetine then fluoxetine plus dextromethorphan, Group B: fluoxetine plus dextromethorphan then fluoxetine
- Results
- None posted
- 24 May 2021: Trial registered
- 20 Jan 2022: Trial started